Rationale The serotonin (5-hydroxytryptamine, 5-HT) system plays an important role in stress-related psychiatric disorders and substance abuse. Our data indicate that stress inhibits the dorsal raphe nucleus (DRN)-5-HT system via stimulation of GABA synaptic activity by the stress neurohormone corticotropin-releasing factor and, more recently, that morphine history sensitizes DRN-5-HT neurons to GABAergic inhibitory effects of stress. Objectives We tested the hypothesis that DRN GABA A receptors contribute to stress-induced reinstatement of morphine-conditioned place preference (CPP). Methods First, we tested if activation of GABA A receptors in the DRN would reinstate morphine CPP. Second, we tested if blockade of GABA A receptors in the DRN would attenuate swim stress-induced reinstatement of morphine CPP. CPP was induced by morphine (5 mg/kg) in a 4-day conditioning phase followed by a conditioning test. Upon acquiring conditioning criteria, subjects underwent 4 days of extinction training followed by an extinction test. Upon acquiring extinction criteria, animals underwent a reinstatement test. For the first experiment, the GABA A receptor agonist muscimol (50 ng) or vehicle was injected into the DRN prior to the reinstatement test. For the second experiment, the GABA A receptor antagonist bicuculline (75 ng) or vehicle was injected into the DRN prior to a forced swim stress, and then, animals were tested for reinstatement of CPP. Results Intraraphe injection of muscimol reinstated morphine CPP, while intraraphe injection of bicuculline attenuated swim stress-induced reinstatement.
Introduction
Drug addiction is characterized by repeated relapse to drug use even after a prolonged period of abstinence. This relapse is often triggered by exposure to stress (Goeders 2003; Sinha 2008) . Stress-induced relapse has been modeled in animals with conditioned place preference (CPP) and self-administration, in which stress, e.g., forced swim, can reinstate drug-seeking behavior in animals with a history of drug taking (Conrad et al. 2010; Katz & Higgins 2003; Shaham et al. 2003; Staub et al. 2012) . Understanding the neurobiological mechanisms underlying stress-induced drug relapse could contribute to the development of novel therapeutic strategies for drug addiction.
In response to stress, corticotropin-releasing factor (CRF) is released by the hypothalamus as the primary neurohormone which activates the hypothalamic-pituitary-adrenal (HPA) axis (Habib et al. 2001; Strohle & Holsboer 2003) . The critical role of CRF in stress-induced reinstatement has been identified for several addictive drugs including heroin, cocaine, and alcohol (Buffalari et al. 2012; Le et al. 2011; Shaham et al. 1997; Shalev et al. 2010) . Interestingly, evidence suggests that the effect of CRF in stress-induced reinstatement may be independent of the HPA axis but, instead, is related to its actions at extrahypothalamic sites (Erb et al. 1998; Marinelli et al. 2007; Shaham et al. 1997; Shalev et al. 2010) , such as the dorsal raphe nucleus (DRN).
The DRN, which contains the majority of the serotonin (5-hydroxytryptamine, 5-HT) neurons projecting to the forebrain (Jacobs & Azmitia 1992) , plays an important role in stress-related psychiatric disorders (Baldwin & Rudge 1995; Mann 1999) . DRN-5-HT neurons are strongly regulated by CRF in a bimodal manner, in which activation of different CRF receptor subtypes can have opposing effects on DRN-5-HT neurons (Valentino et al. 2010) . Although there is evidence that 24 h after exposure to swim stress, DRN-5-HT neurons exhibited increased excitability (Lamy & Beck 2010) , acute stress as well as intra-DRN injection of low doses of CRF inhibit DRN-5-HT activity (Kirby et al. 2000; Price et al. 1998 Price et al. , 2002 , resulting in changes of 5-HT release in targeted brain regions, e.g., decreased 5-HT levels in the lateral septum, amygdala, and thalamus-hypothalamus but increased 5-HT in the striatum (Briones-Aranda et al. 2005; Kirby et al. 1995; .
The inhibitory effect of acute stress and CRF on 5-HT neurons is indirectly mediated by GABAergic interneurons in the DRN. Anatomical studies showed that DRN GABAergic interneurons receive strong CRF-containing projections and have dense expression of CRF-R1 receptors (Roche et al. 2003) . Electrophysiological studies showed direct evidence that CRF activates CRF-R1 receptors on GABAergic neurons, causing increased presynaptic release of GABA onto DRN-5-HT neurons (Kirby et al. 2008) . Behavioral studies further confirm the involvement of GABA transmission in the DRN in anxiety-related and defensive responses (Takahashi et al. 2010b; Zangrossi et al. 2001) .
The role of GABA transmission in the DRN-5-HT system in drug-related stress disorders is also supported by emerging evidence. For example, infusion of GABA agonists into the DRN reduces cocaine-induced anxiety (Ettenberg et al. 2011 ). Infusion of a GABA A , but not GABA B , receptor agonist muscimol in the DRN escalates alcohol-heightened aggression (Takahashi et al. 2010a) . Moreover, injecting muscimol into the medial raphe nucleus (MRN), another major source of 5-HT projections to forebrain sites with shared and distinct projections compared to the DRN (Vertes et al. 1999) , reinstates alcohol-seeking behavior (Le et al. 2008) . Recent data from our laboratory indicate that morphine history sensitizes DRN-5-HT neurons to the GABAergic inhibitory effects of stress (Staub et al. 2012) , suggesting that the subjects with morphine history may be more vulnerable to the effects of stress. However, there is no direct evidence to date showing that activation of the DRN GABA system causes stress-induced reinstatement of morphine-seeking behavior. Therefore, in our current experiment, we hypothesized that GABA A receptors in the DRN contribute to stress-induced reinstatement of morphine CPP. To test this hypothesis, in the first experiment, we tested if activation of GABA A receptors in the DRN would induce reinstatement in abstinent subjects with a history of morphine CPP. In the second experiment, we tested if blockade of GABA A receptors in the DRN would attenuate swim stress-induced reinstatement of morphine CPP.
Materials and methods

Animals
Male Sprague-Dawley rats (Taconic Farms, Germantown, NY) arrived in the laboratory at the weight of 225-250 g and were housed two to three per cage under standard temperature (20°C) and humidity (40 %) on a 12-h light/dark cycle (lights on at 7:00 a.m.). After 6-7 days of acclimation, rats received intracranial implantation of a guide cannula into the dorsal raphe nucleus, after that they were singly housed throughout the rest of experiment. Food and water were provided ad libitum. All subjects were observed and/or weighed daily to assess general health and responsiveness to drug exposure. Animal protocols were approved by the Temple University Institutional Animal Care and Use Committee and were conducted in accordance to the National Research Council Guide for the Care and Use of Laboratory Animals.
Surgery
A guide cannula was implanted with a stereotaxic apparatus aimed at the midline of the dorsal raphe nucleus. Rats were anesthetized with a ketamine/acepromazine mixture (40.5/0.4-mg/kg, intramuscular), and the skull was immobilized. A 26-gauge guide cannula (Plastics One, Roanoke, VA, USA) was implanted using the following coordinates: −7.8 mm caudal to bregma, −2.2 mm from the midline, and −4.6 mm ventral from the brain surface at a 25°angle to bypass the sagittal sinus. The cannula was secured to the skull with the use of dental cement and three stainless steel screws. An obturator was inserted into the guide cannula to maintain the patency of the cannula and to prevent infection. Animals were allowed to recover for 6-7 days before the beginning of behavioral testing.
Drugs
Morphine (made by the Research Triangle Institute and generously supplied by the National Institute on Drug Abuse) was dissolved in 0.9 % saline and administered subcutaneously in a dose of 5 mg/kg. This dose was selected because it induced a robust CPP that could be extinguished and reinstated by exposure to a forced swim stressor in our previous study (Staub et al. 2012) . To activate GABA A receptors in the DRN, a GABA A agonist muscimol (3 mM) (Sigma-Aldrich, St. Louis, MO) was prepared in 0.9 % saline in a final dose of 50 ng/0.5 μl (Ferreira & Menescal-deOliveira 2012; Tomkins & Fletcher 1996; Tomkins et al. 1994a , Tomkins et al. 1994b ) and infused into the DRN. To block GABA A receptors, a water-soluble GABA A antagonist bicuculline methobromide (3.25 mM) (Sigma-Aldrich, St. Louis, MO) was prepared in 0.9 % saline in a final dose of 75 ng/0.5 μl and infused into the DRN (Duncan & Congleton 2010; Tao & Ma 2012) . The doses were chosen on the basis of previous publications as well as pilot studies, using the criteria of behavioral efficacy with few confounding side effects. For muscimol, a lower dose (25 ng) than current selected one was ineffective at inducing reinstatement, whereas the selected dose of muscimol (50 ng) was at the very edge of sedation-producing effects. At the dose of 50 ng, two out of ten animals from saline-conditioned group and two out of ten animals from morphine-conditioned group showed significant impairment in locomotion, making fewer than five crosses between the two chambers of the CPP apparatus in 15 min, and were removed from the study. For bicuculline, about 25 % of the animals demonstrated turning behaviors as other labs have described in mice for intra-DRN bicuculline in the upper range of the dose-response curve (Takahashi et al. 2010a, b) . This behavior was observed immediately following the drug injection but largely resolved by the reinstatement session and did not seem interfere with their exploration, so no rats were excluded from the study. Infusions were made over 1 min, and the infusion needle was left in place for an additional 2 min before it was removed.
Conditioned place preference and extinction
The CPP procedure was conducted as described previously (Staub et al. 2012) . The CPP chambers consisted of two distinct boxes and were designed and tested to ensure that animals would show no inherent preference for one side or another; all CPP experiments were conducted using an unbiased procedure. All experimental works were performed during the light phase under low lighting conditions. For morphine-conditioned subjects, the conditioning phase consisted of 4 days (days 1-4) of subcutaneous injections of morphine (5 mg/kg) or saline given alternately in the morning (10 a.m.) and afternoon (4 p.m.) sessions (6 h apart), and each injection was followed by immediate confinement of the rat to its drug-or saline-paired chamber for 45 min (Fig. 1) . For saline-conditioned controls, rats were given only saline. Injections were counterbalanced for chamber and injection time of the day. On the 5th day, rats were tested for conditioning by placing subjects in the CPP chambers for 15 min with free access to both sides. Successful conditioned place preference was defined as time in drugminus saline-paired chamber at ≥100 s (Herzig & Schmidt 2004 , 2005 . If the difference was below 100 s, then the rat was removed from the experiment.
For extinction of morphine CPP, all rats first underwent 4 days of extinction sessions (days 6-9), which had the same design as the conditioning phase ( Fig. 1) , except that no morphine was administered. On day 10, rats were tested for extinction by placing them in the CPP chambers for 15 min with free access to both sides. Successful extinction of CPP was defined as the time in the drug-minus saline-paired chamber at <100 s. Rats that passed the extinction test were tested with reinstatement on the next day. Rats that did not pass the first extinction test were given additional extinction sessions by placing them in the CPP chambers and testing with an extinction test after each extinction session until they reached the successful extinction criteria (days 11-15) . If the rats could not reach the extinction criteria on the fourth extinction test (day 16), they were removed from the experiment. The reinstatement test was performed on the day following a successful extinction test.
Experiment 1: effect of GABA A receptor agonist in the DRN on reinstatement of morphine CPP To test the hypothesis that activation of GABA A receptors in the DRN would induce reinstatement in abstinent subjects with a history of morphine CPP, the GABA A receptor agonist muscimol or vehicle was injected into the DRN 20 min prior to the reinstatement test. For the reinstatement test, rats were placed in the CPP chambers for 15 min with free access to both sides, and their behavior was videotaped for analysis.
Experiment 2: effect of GABA A receptor antagonist in the DRN on swim stress-induced reinstatement of morphine CPP To test the hypothesis that blockade of GABA A receptors in the DRN would attenuate swim stress-induced reinstatement of morphine CPP, the GABA A receptor antagonist bicuculline or vehicle was injected into the DRN 15 min prior to a 6-min forced swim stress (placed in a swim tank that is 20 cm in diameter and filled with 21-22°C water to a depth of 30 cm); then after a 20-min drying off period, animals were tested for reinstatement of CPP as described above.
Histology
After completion of behavioral testing, all animals were euthanized with carbon dioxide overdose, and 0.5 μl of Evans blue dye (Sigma-Aldrich, St. Louis, MO) was injected through the guide cannula. Brains were removed and sliced in 30-μm frozen sections. Placements of cannulae were verified by comparing the slides with a rat brain atlas by Paxinos and Watson (Paxinos & Watson 1998) .
Data analysis
For experiment 1, the time spent on the drug-paired side minus the unpaired side in morphine-or saline-conditioned groups was analyzed using a two-way mixed measures ANOVA with phase (conditioning, extinction, vs. reinstatement) as a within-subjects factor and reinstatement drug (intra-DRN muscimol vs. intra-DRN saline) as a betweensubjects factor. Paired samples t tests (two-tailed) with Bonferroni correction were conducted as follow-up tests. According to our hypothesis, a preplanned t test was conducted to compare reinstatement of morphine CPP between the intra-DRN muscimol and intra-DRN saline group since the two groups of animals were treated identically in conditioning and extinction tests.
For experiment 2, the time spent on the drug-paired side minus the unpaired side in morphine-or saline-conditioned groups was analyzed using a two-way mixed measures ANOVA with phase (conditioning, extinction, vs. reinstatement) as a within-subjects factor and reinstatement treatment (bicuculline + swim, bicuculline, vs. saline + swim) as a between-subjects factor. One-way ANOVA and post hoc Tukey tests as well as one-way repeated measures ANOVA and paired sample t tests with Bonferroni correction were conducted as follow-up tests.
Results
Histology
Each rat received an injection of muscimol, bicuculline, or saline into the DRN through a permanent guide cannula. The site of injection was confirmed by histological analysis after behavioral tests (Fig. 2) . For each subject, an identical volume and procedure was used for injection of Evans blue dye to confirm that there was no diffusion beyond the boundaries of the DRN. Only the animals with correct location of injection were included in the behavioral analysis (76 out of 132 for morphine-and saline-conditioned group).
Behavior CPP was used to evaluate drug reward during conditioning, extinction, and reinstatement tests. As we described previously (Staub et al. 2012) , animals that did not reach the successful criteria for conditioning or extinction were eliminated from this study (see methods, "Conditioned place preference and extinction") because the study focused on the role of GABA A receptors in the DRN in stress-induced reinstatement. The success rate for conditioning was 83 % (81 out of 98), and for extinction, this was 91 % (74 out of 81).
Experiment 1: GABA A receptor agonist in the DRN-reinstated morphine CPP
The morphine-conditioned group spent significantly more time on the drug-paired side than the saline-paired side in conditioning test, and this preference was extinguished after repeated extinction training. Intra-DRN injection of muscimol, but not saline, reinstated the preference for the drug-paired side (Fig. 3a, n=8/ =3 .536, p<0.01) were different. The preplanned t tests (see methods, "Data analysis") revealed that reinstatement in the intra-DRN muscimol group was different from that in the intra-DRN saline group (t (14) =2.221, p<0.05), and reinstatement was different from extinction in the intra-DRN muscimol group (t (7) =4.887, p<0.01), but not in the intra-DRN saline group. For salineconditioned groups, the two-way phase × reinstatement drug ANOVA revealed no main effects or interaction (Fig. 3b ).
Experiment 2: GABA A receptor antagonist in the DRN prevented swim stress-induced reinstatement of morphine CPP
The morphine-conditioned group spent significantly more time on the drug-paired side than the saline-paired side in the conditioning test, and this preference was extinguished after repeated extinction training. Swim stress reinstated morphine CPP in animals that received intra-DRN injection of saline, but this effect was blocked by intra-DRN injection of bicuculline. Intra-DRN injection of bicuculline itself did not reinstate previously extinguished morphine CPP (Fig. 4a) , similar to saline controls from experiment 1 (Fig. 3a) . The two-way phase × reinstatement drug ANOVA revealed main effects of phase [F (2,46) =−3.795, p<0 .01] were different from extinction. In the bicuculline and bicuculline + swim groups, conditioning was different from extinction [bicuculline, t (7) = 6.317, p<0.001; bicuculline + swim, t (7) =10.423, p<0.001], but no other comparisons showed significant differences. One-way ANOVAs revealed a main effect of reinstatement treatment in reinstatement [F (2,23) =4.433, p<0.05], but not other phases. Post hoc analysis showed that reinstatement in the intra-DRN bicuculline + swim group was different from the intra-DRN saline + swim group (p<0.05), but reinstatement did not differ between the other two groups. For saline-conditioned groups, the two-way phase × reinstatement treatment ANOVA revealed no main effects or interaction (Fig. 4b) . Moreover, from experiment 1, intra-DRN injection of saline did not reinstate CPP in either morphine-or salineconditioned animals (Fig. 3) .
Discussion
The primary finding in the current study is that GABA transmission in DRN-5-HT system is critical to stressinduced reinstatement of morphine CPP. Intra-DRN injection of a GABA A receptor agonist induced reinstatement of morphine CPP, while intra-DRN injection of a GABA A receptor antagonist blocked swim stress-induced reinstatement. These data provide behavioral evidence that stressinduced inhibition of DRN-5-HT neurons could trigger reinstatement of drug-seeking behavior.
While the roles of dopaminergic and glutamatergic circuits in drug addiction and relapse are well-established, these data add evidence to a growing literature implicating the serotonin system in the neurobiological mechanisms underlying reinstatement of drug-seeking behavior (for reviews, (Filip et al. 2010; Kirby et al. 2011) . For example, systemic stimulation of the 5-HT system with 5-HTselective reuptake inhibitors or 5-HT-releasing agents suppresses both cue-elicited cocaine reinstatement (Baker et al. 2001; Burmeister et al. 2003) and also stress-induced reinstatement of alcohol-seeking behavior in rats (Le et al. 1999) . Studies focusing on serotonin receptor types suggest that different types of serotonin receptors may play opposite roles in reinstatement (Filip et al. 2010) . For example, blockade of 5-HT 2A receptors attenuates both drug-and cue-induced reinstatement (Filip 2005; Fletcher et al. 2002; Nic Dhonnchadha et al. 2009 ), whereas stimulation of 5-HT 2C receptors attenuates cocaine-induced, cue-induced Neisewander & Acosta 2007) , and stress-induced cocaine reinstatement ). Although only a few studies have investigated the role of the sources of the serotonergic projections in drug (alcohol and cocaine) reinstatement, their results are consistent with our findings, suggesting that inhibition of 5-HT cell bodies reinstates drug-seeking behavior, whereas stimulation of 5-HT cell bodies blocks stressinduced reinstatement (Land et al. 2009; Le et al. 2002 Le et al. , 2008 . Therefore, the serotonergic system could be a novel target for the treatment of addiction and prevention of relapse to multiple drugs of abuse.
Together with the evidence that opioid history also influences the GABAergic transmission in the DRN (for reviews, see Kirby et al. (2011) ), the current data provide a potential mechanism to explain the high degree of comorbidity of affective disorders with opioid dependence and high vulnerability to stress-induced reinstatement in opioiddependent subjects (Sinha 2008) . The primary functional target of opioid compounds in the DRN is mu-opioid receptors on GABAergic interneurons (Kalyuzhny & Wessendorf 1997) . Acute opioid administration inhibits GABAergic neurons via mu-opioid receptors thus indirectly excites DRN-5-HT neurons, increasing 5-HT levels in projection brain regions (Jolas & Aghajanian 1997; Tao & Auerbach 2002) . Although there is no direct evidence showing that excitation of DRN-5-HT by opioids produces euphoria, the fact that the DRN supports intracranial self-stimulation suggests that the DRN-5-HT system may play a role in reward and reinforcement (Rompre & Boye 1989; Simon et al. 1976 ; but see Houdouin et al. 1991) . However, after repeated opioid exposure, the stimulatory effect of morphine on DRN-5-HT neurons is largely reduced or absent due to tolerance to the effect of mu-receptor activation on GABAergic neurons (Tao et al. 1998) . Moreover, during withdrawal, the activity of DRN-5-HT neurons is also reduced due to an increase of GABA synaptic activity (Jolas et al. 2000) . More recently, our data indicated that morphine history sensitizes DRN-5-HT neurons to GABA inhibition in response to stress, and this sensitization may explain the vulnerability of subjects with an opioid history to stress-induced relapse (Staub et al. 2012) . In support of the above hypothesis, our current experiments establish a causal relationship between GABA A receptors in the DRN and stress-induced reinstatement.
5-HT hypofunction is known to increase impulsive behaviors including motor impulsivity and choice impulsivity (Cardinal 2006) , and impulsivity is an established risk factor for drug addiction and relapse in both human and animal studies (for review, see Kirby et al. (2011) ). For example, inhibition of DRN-5-HT neurons with a 5-HT 1A receptor agonist impairs the animal's ability to wait for long-delayed rewards (Miyazaki et al. 2012) . Moreover, rats receiving intra-MRN infusion of muscimol show impaired performance in a five-choice serial reaction time task (5-CSRTT) (Le et al. 2008) , which is a test for sustained attention and impulsivity. In addition, rats showing high impulsivity in the 5-CSRTT have persistent relapse behavior compared with low impulsive counterparts (Economidou et al. 2009 ). Therefore, inactivation of DRN-5-HT neurons by muscimol in our study may increase impulsivity, contributing to reinstatement of morphine CPP.
A few limitations of the present study need to be mentioned, and future studies will be required to fully characterize the role of GABA A receptors in the DRN in stressinduced reinstatement. First, when the GABA A receptor agonist and antagonist were injected into the DRN, they influenced not only 5-HT neurons but also other cell types and neuronal fibers expressing GABA A receptors. To resolve this limitation, we plan to use a conditional knockout approach in the future studies to silence or activate GABA A receptors in only DRN-5-HT neurons. Second, the DRN is not a homogenous structure but can be divided into ventromedial, dorsomedial, and lateral wing subregions based on their anatomical, neurochemical, and functional characteristics (Calizo et al. 2011 ). In our current study, we did not distinguish the subregions of the DRN mainly due to surgical difficulties and diffusion of injecting solutions. To resolve this limitation, smaller injection volumes targeted to individual DRN subdivision can be used to dissect their distinct contributions to stress-induced reinstatement. Third, the roles of CRF and its receptor subtypes in the DRN in stress-induced reinstatement have not been tested. Our current study was based on the rationale that stress indirectly inhibits DRN-5-HT neurons by activation of CRF-R1 receptors expressed on GABAergic interneurons (Valentino et al. 2010 ). Although we showed that activation of GABA A receptors in the DRN was critical for stress-induced reinstatement of CPP, understanding the role of CRF in the DRN in stress-induced reinstatement is necessary for fully supporting the hypothesis, especially considering the bimodal influence of CRF on DRN-5-HT neurons (Valentino et al. 2010) . Therefore, to resolve this limitation, the effects of intra-DRN injection of CRF-R1 and CRF-R2 receptor-selective agonists and antagonists on swim stressinduced reinstatement of morphine CPP will be tested in our future studies. Lastly, although CPP model is widely used for inferring the hedonic value of addictive drugs, questions remain whether it is an adequate procedure to represent active drug-seeking behaviors that characterize drug addiction in humans (Sanchis-Segura & Spanagel 2006) . To resolve this limitation, self-administration, which can measure voluntary drug intake in animals, is currently under development in our laboratory and will be used to confirm the current findings. Self-administration can better represent addiction-like behavior (Sanchis-Segura & Spanagel 2006), such as progressive ratio schedule to assess motivation to seek drug (Roberts et al. 1989) , punished responding to model compulsivity (Vanderschuren & Everitt 2004) , and extended access to model binge use (Mantsch et al. 2004) .
In summary, this study shows that forced swim stress induced reinstatement of previously extinguished morphine CPP, and GABA transmission in DRN-5-HT system is critical for this reinstatement. Together with our previous data, it is suggested that adaptations of GABAergic synaptic transmission caused by opioid history may contribute to enhanced relapse vulnerability in these subjects.
